Eli Lilly director receives deferred stock award

Accepted by SEC EDGAR 07/21/2026 - 04:40 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ELI LILLY & Co director Gabrielle Sulzberger reported a grant/award acquisition of 4.3232 shares of common stock on July 20, 2026 at $1,146.90 per share. At her election, this amount was deferred as stock units under the Lilly Directors' Deferral Plan and will be settled in shares after her separation from service. Following this award, she directly holds 2,999.7188 shares of Eli Lilly common stock.

Insider Trade Summary

Grant/Award: 4.3232 shares

Grant/Award 1 txn

Insider Sulzberger Gabrielle

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	4.3232	$1,146.90	$5K

Holdings After Transaction: Common Stock — 2,999.7188 shares (Direct)

Holdings Before and After: Common Stock, 2,995.3956 to 2,999.7188 shares (Direct)

Footnotes (1)

1. F1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Key Figures

Shares awarded: 4.3232 shares Award price per share: $1,146.9000 Shares owned after transaction: 2,999.7188 shares +1 more

4 metrics

Shares awarded 4.3232 shares Grant/award acquisition of common stock on 2026-07-20

Award price per share $1,146.9000 Value used for the 4.3232-share stock award

Shares owned after transaction 2,999.7188 shares Director’s direct beneficial ownership following the award

Transaction date 2026-07-20 Date of the reported grant/award acquisition

Key Terms

Lilly Directors' Deferral Plan, stock units, separation from service

3 terms

Lilly Directors' Deferral Plan financial

"as stock units under the Lilly Directors' Deferral Plan and will be settled"

stock units financial

"have been deferred in lieu of cash compensation as stock units under"

Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.

separation from service financial

"will be settled in shares of common stock following the reporting person's separation from service"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Eli Lilly (LLY) director Gabrielle Sulzberger report?

Director Gabrielle Sulzberger reported a grant/award acquisition of 4.3232 shares of Eli Lilly common stock on July 20, 2026. The value was based on a price of $1,146.90 per share, and the award was taken instead of cash compensation.

How many Eli Lilly (LLY) shares does Gabrielle Sulzberger hold after this Form 4 transaction?

After the reported award, Gabrielle Sulzberger directly holds 2,999.7188 shares of Eli Lilly common stock. This reflects her updated direct beneficial ownership following the 4.3232-share grant/award acquisition recorded on July 20, 2026.

Was the Eli Lilly (LLY) Form 4 transaction by Gabrielle Sulzberger a market purchase or a stock award?

The transaction is a grant/award acquisition, not an open-market purchase. Sulzberger received 4.3232 shares of Eli Lilly common stock as compensation, valued at $1,146.90 per share, and elected to defer this amount into stock units.

How does the Lilly Directors' Deferral Plan affect Gabrielle Sulzberger’s Eli Lilly (LLY) stock award?

Sulzberger elected to defer the 4.3232-share award into stock units under the Lilly Directors' Deferral Plan. These units represent deferred compensation and will be settled in shares of common stock only after her separation from service as a director.

What price per share was used for Gabrielle Sulzberger’s Eli Lilly (LLY) stock award?

The reported stock award used a per-share value of $1,146.90 for Eli Lilly common stock. This price applies to the 4.3232 shares granted to director Gabrielle Sulzberger on July 20, 2026, which she deferred as stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sulzberger Gabrielle

(Last) (First) (Middle)

LILLY CORPORATE CENTER

(Street)

INDIANAPOLIS INDIANA 46285

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/20/2026		A		4.3232(1)	A	$1,146.9	2,999.7188	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Remarks:

	/s/ Jonathan Groff for Gabrielle Sulzberger, pursuant to authorization on file	07/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)